These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27287177)

  • 21. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.
    Alvarado HL; Abrego G; Garduño-Ramirez ML; Clares B; Calpena AC; García ML
    Nanomedicine; 2015 Apr; 11(3):521-30. PubMed ID: 25659643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendrimer nanoparticles for ocular drug delivery.
    Kambhampati SP; Kannan RM
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation.
    Pittalà V; Salerno L; Romeo G; Siracusa MA; Modica MN; Romano GL; Salomone S; Drago F; Bucolo C
    Eur J Pharmacol; 2015 Apr; 752():78-83. PubMed ID: 25704612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
    de la Fuente M; Raviña M; Paolicelli P; Sanchez A; Seijo B; Alonso MJ
    Adv Drug Deliv Rev; 2010 Jan; 62(1):100-17. PubMed ID: 19958805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production, characterization and application of nanocarriers made of polysaccharides, proteins, bio-polyesters and other biopolymers: A review.
    Samrot AV; Sean TC; Kudaiyappan T; Bisyarah U; Mirarmandi A; Faradjeva E; Abubakar A; Ali HH; Angalene JLA; Suresh Kumar S
    Int J Biol Macromol; 2020 Dec; 165(Pt B):3088-3105. PubMed ID: 33098896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.
    Shi S; Zhang Z; Luo Z; Yu J; Liang R; Li X; Chen H
    Sci Rep; 2015 Jun; 5():11337. PubMed ID: 26067670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogel Biomaterials for Application in Ocular Drug Delivery.
    Lynch CR; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
    Front Bioeng Biotechnol; 2020; 8():228. PubMed ID: 32266248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions.
    Lalu L; Tambe V; Pradhan D; Nayak K; Bagchi S; Maheshwari R; Kalia K; Tekade RK
    J Control Release; 2017 Dec; 268():19-39. PubMed ID: 28756272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopolymer-based nanoparticles with tunable mucoadhesivity efficiently deliver therapeutics across the corneal barrier.
    Kimna C; Winkeljann B; Hoffmeister J; Lieleg O
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111890. PubMed ID: 33579502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of an anti-inflammatory composite nanosystem and evaluation of its potential for ocular drug delivery.
    Du Toit LC; Govender T; Carmichael T; Kumar P; Choonara YE; Pillay V
    J Pharm Sci; 2013 Aug; 102(8):2780-805. PubMed ID: 23828405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considerations for Polymers Used in Ocular Drug Delivery.
    Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
    Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery.
    Kim J; Schlesinger EB; Desai TA
    Ther Deliv; 2015; 6(12):1365-76. PubMed ID: 26652282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diclofenac/biodegradable polymer micelles for ocular applications.
    Li X; Zhang Z; Li J; Sun S; Weng Y; Chen H
    Nanoscale; 2012 Aug; 4(15):4667-73. PubMed ID: 22732776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
    Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
    Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of layer-by-layer (LbL) assembled CaCO(3)-carriers on macrophage signaling cascades.
    Lessig J; Neu B; Reibetanz U
    Biomacromolecules; 2011 Jan; 12(1):105-15. PubMed ID: 21142145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotherapies for the treatment of ocular diseases.
    Reimondez-Troitiño S; Csaba N; Alonso MJ; de la Fuente M
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):279-93. PubMed ID: 25725262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.